Play A play symbol Twitter Logo for Twitter Facebook Logo for Facebook YouTube Logo for YouTube LinkedIn Logo for LinkedIn Search A magnifying glass Menu Three lines representing a menu Close An X Chevron An arrow pointing right Phone A ringing phone Email An envelope Toolkit A crossed screwdriver and wrench Guide A clipboard Report A piece of paper with writing on it Network A network of connected dots Research A microscope Business A pair of office towers Devices A hand holding a tablet computer Therapeutics A cross Software A box with a CD next to it Devices A tablet computer Therapeutics A pill bottle with a cross on it Software A box with a CD next to it Event A calendar News An open newspaper Infographic A page of text with images in it Video A camera in a circle Editorial A newspaper Media Release A loudspeaker Time A clock Location A pin represeting a location Ideation A lightbulb brain hybrid Proof of Concept A thumbs up Preclinical / Prototype A pen and wrench Clinical Validation A stethescope Regulatory A clipboard Sales / Marketing A rocket ship

OBI Logo
  • Blog
  • News & Events
  • Stay in touch
  • fr
  • Donate
  • Search
  • Open Menu Close Menu
  • OBI Logo Small
  • About OBI
    • Overview
    • Our Work
    • Our People
    • Atlas of Ontario Neuroscience (AxON)
  • Research & Data Sharing
    • Overview
    • Cerebral Palsy
    • Depression
    • Epilepsy
    • Concussion
    • Neurodegenerative Disorders
    • Neurodevelopmental Disorders
    • Brain-CODE
    • Discovery Starts With You
  • Portfolio Companies
  • Programs & Opportunities
    • Overview
    • Neurotech Entrepreneurship to Validate Emerging Innovations (NERVE)
    • Neurotech Early Research and Development (NERD)
    • Careers
    • Internships
    • Event Funding Program
    • Setting Research Priorities
    • Patient Advisory Committees
    • Growing Expertise in Evaluation and Knowledge Translation (GEEK)
  • Resources
    • Overview
    • Guidelines and Toolkits
    • OBI Public Talks
    • Newsletter
    • Videos
    • Reports
    • Brain Health in Ontario: Forming an Integrated Approach
    • POND Youth Digital Stories
    • Epilepsy, Depression & Anxiety
    • Breaking Stigma, Building Empowerment: A Storytelling Project

Advancing Knowledge

More Stories
Home  /  Featured Stories - Advancing Knowledge
SHARE THIS STORY Share on Facebook Share on Twitter Share on LinkedIn

POND Study Sheds New Light on the Genetics of Autism Spectrum Disorder

The Ontario Brain Institute is making strides to determine the molecular underpinnings of brain disorders. The Province of Ontario’s Neurodevelopmental Network (POND) has released breakthrough research looking at the implications of tandem repeats – genetic patterns that help determine an individual's inherited traits – in the DNA of people impacted by autism. This discovery is poised to help diagnose the disorder earlier, as well as support the development of treatment options.

Current research estimates that genetic factors should be found in anywhere from 50 to 90 percent of individuals with autism. Yet, scientists were only able to identify the genetic factor underlying autism for less than 20 percent of people. Now, through work conducted at the Hospital for Sick Children in Toronto’s Centre for Applied Genomics, “genetic wrinkles'' have been identified after looking through the DNA of some 100,000 families – many of whom have autism.

Dr. Stephen Scherer, Director for the Centre at SickKids and the co-author of the study, described the results, which were published in Nature, as the unveiling of a “whole new class of genes that we didn’t know were involved in autism.”

The team developed an analytic approach that could search and find significant tandem repeat expansions across the entire genome. Dr. Ryan Yuen, Principal Investigator of the study and an Assistant Professor in the Department of Molecular Genetics at the University of Toronto, noted that “we’re effectively searching millions of repetitive regions of DNA simultaneously and decoding them in a way no one has ever been able to do.”

Data Sharing enabled by Brain-CODE

Brain-CODE, the Ontario Brain Institute’s (OBI) state-of-the-art neuroinformatics platform designed to store, manage, and analyze data, oversaw the development of four agreements to share key insights collected by OBI’s research programs with external research programs. These will help advance international research efforts aimed at:

● Improving diagnostic criteria for depression;

● Developing better tools to help manage symptoms of a concussion;

● And improve recovery outcomes in children with concussions.

Depression in Clear Language

The Ontario Brain Institute’s CAN-BIND program has launched a new series of articles entitled “Research Findings in Clear Language” to translate the technical jargon used in research studies into plain language summaries. The series aims to make CAN-BIND research more accessible to the broader community. CAN-BIND trainees are contributing writers of the articles, while CAN-BIND staff and the Community Advisory Committee – composed of people with lived experience – edited the articles. The first research studies can be viewed on the CAN-BIND website.

EpLink Launches an Updated Version of the Epilepsy Guidelines

Ontario Brain Institute’s epilepsy research program, EpLink, released updated clinical guidelines to make sure the latest information for improved epilepsy care was available to clinicians. A similar patient-friendly version was created to empower individuals living with epilepsy with the knowledge they need to self-manage much of their care. The 2020 version of the Clinical Guidelines for The Management of Epilepsy in Adults and Children outlines evidence-based recommendations along with supporting materials on issues such as Status Epilepticus, Valproic Acid, Epilepsy and Depression, and Psychogenic Non-Epileptic Seizures.

ONDRI/NIBS Team Celebrates Investment in Data Curation

Data sharing is a key component of a learning health system – which requires protocols in place to make sure high-quality data are collected and curated so researchers can generate reproducible and accurate findings from their analysis.

NIBS, the Neuroinformatics & Biostatistics research platform, is devoted to the review, cleaning, and analysis of the data from all the Ontario Brain Institute’s Neurodegenerative Disease Research Initiative’s (or ONDRI) assessment platforms. The platform plays a vital role in improving data sharing and collaboration for neurodegenerative disease research.

Further investment in the NIBS data curation platform has allowed for the development of standardized methods to achieve high-quality data across complex assessments and neurodegenerative disease groups, which organize and share data in a meaningful way for researchers and clinicians to study.

back to report next section
Collaborative Research
  • © 2022 Ontario Brain Institute

    1 Richmond Street West, Suite 400

    Toronto, Ontario M5H 3W4

    (647) 847-9000
    1 (866) 637-6301

    • Accessibility for Ontarians with Disabilities Act (AODA) Compliance
    • Stay In Touch
    • Contact Us
    • Twitter profile
    • Facebook profile
    • Blog
    • LinkedIn profile
    • YouTube channel
  • Funding provided, in part, by the Government of Ontario

    Funding Logos